Assignee
LIPOCINE INC
US·75 granted patents·85 pending applications·9,316 citations·filing 1999–2025
Top patents by PatentIndex Score
160 records- 0199US9480690B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2015·Granted Nov 1, 2016·34 cites·24 claims
- 0299US6923988B2Solid carriers for improved delivery of active ingredients in pharmaceutical compositionsLIPOCINE INC·Filed 2003·Granted Aug 2, 2005·857 cites·88 claims
- 0399US6569463B2Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositionsLIPOCINE INC·Filed 2001·Granted May 27, 2003·941 cites·55 claims
- 0499US6451339B2Compositions and methods for improved delivery of hydrophobic agentsLIPOCINE INC·Filed 2001·Granted Sep 17, 2002·514 cites·120 claims
- 0599US6383471B1Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agentsLIPOCINE INC·Filed 1999·Granted May 7, 2002·1k cites·114 claims
- 0699US6309663B1Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agentsLIPOCINE INC·Filed 1999·Granted Oct 30, 2001·561 cites·170 claims
- 0799US6294192B1Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agentsLIPOCINE INC·Filed 1999·Granted Sep 25, 2001·929 cites·74 claims
- 0899US6267985B1Clear oil-containing pharmaceutical compositionsLIPOCINE INC·Filed 1999·Granted Jul 31, 2001·746 cites·184 claims
- 0999US6248363B1Solid carriers for improved delivery of active ingredients in pharmaceutical compositionsLIPOCINE INC·Filed 1999·Granted Jun 19, 2001·1.8k cites·57 claims
- 1098US11052096B2Steroidal compositionsLIPOCINE INC·Filed 2020·Granted Jul 6, 2021·6 cites·7 claims
- 1198US10973833B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2019·Granted Apr 13, 2021·8 cites·25 claims
- 1298US10881671B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2020·Granted Jan 5, 2021·5 cites·30 claims
- 1398US10716794B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2018·Granted Jul 21, 2020·9 cites·27 claims
- 1498US10226473B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2018·Granted Mar 12, 2019·23 cites·21 claims
- 1598US9949985B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Granted Apr 24, 2018·23 cites·26 claims
- 1698US9943527B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Granted Apr 17, 2018·18 cites·19 claims
- 1798US9757390B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Granted Sep 12, 2017·27 cites·27 claims
- 1898US9498485B2Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2015·Granted Nov 22, 2016·23 cites·1 claims
- 1998US9205057B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2015·Granted Dec 8, 2015·42 cites·26 claims
- 2098US7374779B2Pharmaceutical formulations and systems for improved absorption and multistage release of active agentsLIPOCINE INC·Filed 2002·Granted May 20, 2008·332 cites·86 claims
- 2198US6761903B2Clear oil-containing pharmaceutical compositions containing a therapeutic agentLIPOCINE INC·Filed 2001·Granted Jul 13, 2004·305 cites·122 claims
- 2298US6720001B2Emulsion compositions for polyfunctional active ingredientsLIPOCINE INC·Filed 1999·Granted Apr 13, 2004·469 cites·21 claims
- 2398US6468559B1Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methodsLIPOCINE INC·Filed 2000·Granted Oct 22, 2002·169 cites·59 claims
- 2497US11931367B2Oral (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate therapyLIPOCINE INC·Filed 2021·Granted Mar 19, 2024·7 cites·96 claims
- 2597US11370811B1(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and useLIPOCINE INC·Filed 2020·Granted Jun 28, 2022·8 cites·22 claims
- 2697US10799513B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2018·Granted Oct 13, 2020·6 cites·7 claims
- 2797US9358241B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2014·Granted Jun 7, 2016·31 cites·20 claims
- 2897US8865695B2Steroidal compositionsLIPOCINE INC·Filed 2014·Granted Oct 21, 2014·37 cites·9 claims
- 2996US11672807B1Oral testosterone non-undecanoate therapyLIPOCINE INC·Filed 2020·Granted Jun 13, 2023·7 cites·53 claims
- 3096US10881670B2Oral testosterone tridecanoate therapyLIPOCINE INC·Filed 2019·Granted Jan 5, 2021·7 cites·42 claims
- 3196US9757389B2Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2016·Granted Sep 12, 2017·8 cites·18 claims
- 3296US6458383B2Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparinLIPOCINE INC·Filed 2000·Granted Oct 1, 2002·139 cites·94 claims
- 3395US12156881B2Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapyLIPOCINE INC·Filed 2024·Granted Dec 3, 2024·3 cites·31 claims
- 3495US11992496B1Oral testosterone therapyLIPOCINE INC·Filed 2023·Granted May 28, 2024·2 cites·30 claims
- 3595US10709716B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2019·Granted Jul 14, 2020·4 cites·12 claims
- 3695US10022384B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2016·Granted Jul 17, 2018·10 cites·13 claims
- 3795US6982281B1Pharmaceutical compositions and dosage forms for administration of hydrophobic drugsLIPOCINE INC·Filed 2000·Granted Jan 3, 2006·96 cites·33 claims
- 3894US12161651B1Oral testosterone therapyLIPOCINE INC·Filed 2024·Granted Dec 10, 2024·1 cites·30 claims
- 3994US11478485B1Compositions and methods for treating CNS disordersLIPOCINE INC·Filed 2022·Granted Oct 25, 2022·3 cites·30 claims
- 4094US11337987B1Compositions and methods for treating central nervous system disordersLIPOCINE INC·Filed 2021·Granted May 24, 2022·5 cites·26 claims
- 4194US9399069B217-Hydroxyprogesterone ester containing oral compositions and related methodsLIPOCINE INC·Filed 2015·Granted Jul 26, 2016·9 cites·26 claims
- 4293US11969434B1Oral allopregnanolone compositions and methods of useLIPOCINE INC·Filed 2022·Granted Apr 30, 2024·4 cites·33 claims
- 4393US11872235B1Bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one estersLIPOCINE INC·Filed 2022·Granted Jan 16, 2024·1 cites·20 claims
- 4492US11298365B2Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2020·Granted Apr 12, 2022·2 cites·23 claims
- 4592US9358299B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2015·Granted Jun 7, 2016·7 cites·28 claims
- 4691US12208103B1Compositions and methods for treating CNS disordersLIPOCINE INC·Filed 2024·Granted Jan 28, 2025·2 cites·30 claims
- 4791US12186327B2Oral allopregnanolone compositions and methods of useLIPOCINE INC·Filed 2022·Granted Jan 7, 2025·2 cites·42 claims
- 4890US12409185B1Oral allopregnanolone compositions and methods of useLIPOCINE INC·Filed 2024·Granted Sep 9, 2025·1 cites·30 claims
- 4990US9364547B217-hydroxyprogesterone ester containing oral compositions and related methodsLIPOCINE INC·Filed 2014·Granted Jun 14, 2016·7 cites·20 claims
- 5090US9358298B217-hydroxyprogesterone ester containing oral compositions and related methodsLIPOCINE INC·Filed 2014·Granted Jun 7, 2016·7 cites·33 claims
Showing the top 50 of 160 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when LIPOCINE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →